Zap FlabGLP-1 Comparison
Ozempic vs Mounjaro: Which Is Better for Weight Loss?
An evidence-based comparison of the two most popular GLP-1 medications for weight loss — including clinical trial data, costs, side effects, and practical guidance to help you and your doctor decide.
⚡ Quick Verdict
Mounjaro (tirzepatide) produces more weight loss on average — up to 22.5% body weight in clinical trials vs ~10% for Ozempic (semaglutide 1mg) or ~16.9% for Wegovy (semaglutide 2.4mg).
However, Ozempic is more widely prescribed and has a longer real-world track record. It was FDA-approved in 2017 vs 2022 for Mounjaro.
Both are highly effective. The best choice depends on your insurance coverage, medication availability, health profile, and what your provider recommends.
Side-by-Side Comparison
Ozempic
Generic: Semaglutide
Manufacturer: Novo Nordisk
Mechanism: GLP-1 receptor agonist
FDA Approved: Type 2 diabetes (2017)
Avg Weight Loss: 5–10% (1mg dose)
Dosing: Once weekly injection
Cost (self-pay): ~$499/month
Doses: 0.25mg, 0.5mg, 1mg, 2mg
Side Effects: Nausea, diarrhea, constipation, vomiting
Mounjaro
Generic: Tirzepatide
Manufacturer: Eli Lilly
Mechanism: Dual GIP/GLP-1 receptor agonist
FDA Approved: Type 2 diabetes (2022)
Avg Weight Loss: 15–22.5% (highest dose)
Dosing: Once weekly injection
Cost (self-pay): ~$599–699/month
Doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg
Side Effects: Nausea, diarrhea, constipation, decreased appetite
How They Work
💉
Ozempic
Semaglutide
GLP-1 Receptor Agonist
Mimics the natural GLP-1 hormone your gut produces after eating. This hormone:
- ✓ Signals your brain to feel full
- ✓ Slows stomach emptying
- ✓ Regulates blood sugar
- ✓ Stimulates insulin release
Targets one hormone pathway — but does it very effectively. Same active ingredient in Wegovy (the FDA-approved weight loss version at higher dose).
⚡
Mounjaro
Tirzepatide
Dual GIP + GLP-1 Agonist
First-of-its-kind dual mechanism that activates two hormone receptors at once:
- ✓ GLP-1 — appetite suppression
- ✓ GIP — enhanced fat metabolism
- ✓ Synergistic effect
- ✓ Greater weight loss potential
Think of it as attacking weight loss from two angles instead of one. Zepbound is the FDA-approved weight loss version.
💡 Why does dual mechanism matter? GIP is another incretin hormone that works alongside GLP-1. By activating both pathways, tirzepatide produces stronger appetite suppression and improved glucose control. Clinical trials consistently show this translates to significantly more weight loss compared to GLP-1-only medications.
Clinical Trial Data
Ozempic — SUSTAIN Trials
Ozempic was studied in the SUSTAIN clinical trial program, primarily for type 2 diabetes management. At the standard 1mg dose, participants lost an average of 5–10% of their body weight over 30–56 weeks. While weight loss wasn’t the primary endpoint, it was a consistent and significant secondary finding.
The higher-dose version, Wegovy (semaglutide 2.4mg), was studied in the STEP trials specifically for weight management, achieving approximately 16.9% weight loss over 68 weeks in the STEP 1 trial.
Mounjaro — SURMOUNT-1 Trial
The landmark SURMOUNT-1 trial studied tirzepatide specifically for weight loss in adults with obesity or overweight. Results were dramatic: at the highest dose (15mg), participants lost an average of 22.5% of their body weight over 72 weeks. Even at the lowest studied dose (5mg), weight loss averaged 15%.
Over one-third of participants on the highest dose lost more than 25% of their body weight — results previously only seen with bariatric surgery.
🏆 Head-to-Head: SURMOUNT-5
The SURMOUNT-5 trial was the first direct head-to-head comparison of tirzepatide vs semaglutide for weight loss. The results: tirzepatide (15mg) produced 20.2% weight loss vs 13.7% for semaglutide (2.4mg) over 72 weeks. Tirzepatide was the clear winner in this direct comparison, with a 47% greater relative weight reduction.
Cost Comparison
~$499
Ozempic / month (self-pay via NovoCare)
~$649
Mounjaro / month (self-pay via LillyDirect)
Both medications are now significantly more affordable thanks to 2026 MFN pricing deals. Self-pay Ozempic is $499/month (NovoCare) and Mounjaro is $599–699/month (LillyDirect). New Ozempic patients can get a $199/month intro offer through March 31, 2026. The TrumpRx program will bring prices down to ~$350/month. Both manufacturers also offer savings cards reducing costs to $0–25/month for commercially insured patients.
As of 2026, Medicare Part D now covers Wegovy and Zepbound for obesity, in addition to Ozempic and Mounjaro for diabetes (~$245/month). Check with your specific insurance plan for coverage details and prior authorization requirements.
Side Effects Comparison
Both medications share similar gastrointestinal side effects because they work through related hormone pathways. Most side effects are mild to moderate and tend to improve over time as your body adjusts.
Common to Both
- Nausea (most common)
- Diarrhea
- Constipation
- Vomiting
- Abdominal pain
- Decreased appetite
- Injection site reactions
Serious Warnings
- Thyroid C-cell tumors (boxed warning on both)
- Pancreatitis (rare)
- Gallbladder problems
- Kidney injury (dehydration-related)
- Muscle loss alongside fat loss
- Hypoglycemia (especially with other diabetes meds)
Note: Mounjaro may cause slightly higher rates of GI side effects at its higher doses (10mg–15mg) compared to Ozempic. However, both medications use gradual dose titration to minimize side effects. Resistance training is strongly recommended with either medication to minimize muscle loss during weight loss.
Which One Should You Choose?
Choose Ozempic if…
The proven single-pathway approach
🩺
You’re already taking it for type 2 diabetes and it’s working
💳
Your insurance covers semaglutide but not tirzepatide
📅
You prefer a longer track record — FDA approved 2017
📍
Ozempic or Wegovy is more readily available in your area
👨⚕️
Your doctor recommends starting with a single-mechanism approach
Choose Mounjaro if…
Maximum weight loss potential
🎯
Maximizing weight loss is your primary goal
✅
Your insurance covers tirzepatide (Mounjaro or Zepbound)
🆕
You’re comfortable with a newer medication — FDA approved 2022
🔄
You tried semaglutide and didn’t achieve enough weight loss
⚡
You want the dual-mechanism approach for potentially better results
Always consult with your healthcare provider before starting or switching GLP-1 medications. This comparison is for educational purposes only and is not medical advice.
Frequently Asked Questions
Can you switch from Ozempic to Mounjaro?
Yes, many patients switch from Ozempic (semaglutide) to Mounjaro (tirzepatide) under their doctor’s supervision. Your doctor will typically start you at a lower dose of Mounjaro and titrate up, even if you were on a higher dose of Ozempic. There’s no required washout period, but dose adjustments are important to minimize GI side effects during the transition.
Is Mounjaro stronger than Ozempic?
In terms of weight loss, yes — clinical trials show Mounjaro (tirzepatide) produces significantly more weight loss than Ozempic (semaglutide). The SURMOUNT-5 head-to-head trial showed tirzepatide achieved 20.2% weight loss vs 13.7% for semaglutide. However, “stronger” isn’t always better; the right medication depends on your individual health needs, tolerability, and treatment goals.
Which has fewer side effects — Ozempic or Mounjaro?
Both medications have very similar side effect profiles, primarily gastrointestinal issues like nausea, diarrhea, and constipation. In clinical trials, Mounjaro at higher doses (10mg–15mg) showed slightly higher rates of GI side effects. However, individual responses vary significantly — some people tolerate one much better than the other. Both use gradual dose titration to help your body adjust.
Is one cheaper than the other?
With 2026 MFN pricing, Ozempic is now $499/month self-pay (NovoCare) vs $599–699/month for Mounjaro (LillyDirect). New Ozempic patients can get a $199/month intro offer through March 31, 2026. The TrumpRx program prices them at $350 and $346/month respectively. With commercial insurance and savings cards, costs can drop to $0–$25/month for either. Medicare now covers both at ~$245/month. The real cost difference often comes down to what your specific plan covers.
Can you take Ozempic and Mounjaro together?
No. You should never take Ozempic and Mounjaro at the same time. Both medications activate the GLP-1 receptor, and combining them would significantly increase the risk of severe side effects including dangerous nausea, vomiting, and potentially hypoglycemia. If you want to switch from one to the other, work with your doctor to transition safely.
How long does it take to see results on either medication?
Most people begin noticing weight loss within 4–8 weeks of starting either medication. However, meaningful results (5%+ body weight loss) typically appear around weeks 12–16 as you titrate to higher doses. Peak weight loss is usually reached between weeks 52–72. Mounjaro may show faster initial results due to its dual mechanism, but both require patience during the dose titration period.
Estimate Your Weight Loss
Use our free calculator to see projected weight loss on Ozempic, Wegovy, Mounjaro, or Zepbound based on clinical trial data and your starting weight.
📚 Sources
- • Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity — N Engl J Med 2022; 387:205-216 (SURMOUNT-1)
- • Rodriguez PJ, et al. Tirzepatide vs Semaglutide for Weight Loss in Adults with Overweight or Obesity — N Engl J Med 2024 (SURMOUNT-5)
- • Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity — N Engl J Med 2021; 384:989-1002 (STEP 1)
- • Mounjaro (tirzepatide) Prescribing Information — FDA, 2024
- • Ozempic (semaglutide) Prescribing Information — FDA, 2024
Last reviewed: February 2026